CAS NO: | 161401-82-7 |
规格: | ≥98% |
包装 | 价格(元) |
2mg | 电议 |
5mg | 电议 |
10mg | 电议 |
25mg | 电议 |
50mg | 电议 |
100mg | 电议 |
Molecular Weight (MW) | 453.46 |
---|---|
Formula | C21H28FN3O7 |
CAS No. | 161401-82-7 |
Storage | -20℃ for 3 years in powder form |
-80℃ for 2 years in solvent | |
Solubility (In vitro) | DMSO: 90 mg/mL (198.47 mM) |
Water:<1 mg/mL (slightly soluble or insoluble) | |
Ethanol: N/A | |
SMILES | O=C(N[C@H](C(N[C@@H](C)C(N[C@@H](CC(O)=O)C(CF)=O)=O)=O)C(C)C)OCC1=CC=CC=C1 |
Chemical Name | Z-VAD(OH)-FMK; Z-VAD FMK L-Alaninamide, N-[(phenylmethoxy)carbonyl]-L-valyl-N-[(1S)-1-(carboxymethyl)-3-fluoro-2-oxopropyl]- |
In Vitro | Z-VAD(OH)-FMK is the non-methylated form of Z-VAD-FMK, and useful in studies including recombinant, or purified enzymes. As an irreversible general caspase inhibitor, it is useful for studies involving recombinant, isolated, and purified caspase enzymes. Unlike Caspase Inhibitor I, this inhibitor does not require pretreatment with esterase for in vitro studies. A 10 mM (1 mg/221 μl) solution of Caspase Inhibitor VI in DMSO is also available. |
---|---|
In Vivo | N/A |
Animal model | N/A |
Formulation & Dosage | N/A |
References | Garcia-Calvo M, et al. J Biol Chem. 1998, 273(49), 32608-32613. |